Amphista Therapeutics operates as a biopharmaceutical company.
Amphista Therapeutics has raised €6.7M across 1 funding round from 1 investor, most recently a Series A round in Jul 2020. Based in Motherwell, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-07-04 | Series A |
| €6.7M |
| Advent Life Sciences |
| View deal → |
